Finalist recognition in the Best in Class track highlights the company’s work to redefine the standard of care for women’s pelvic health
NEWTON, Mass.–(BUSINESS WIRE)–Axena Health, Inc. (Axena Health), a women’s health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced it has been named a finalist for the Digital Health Hub Foundation – Digital Health & AI Awards 2026 at HLTH. Selected from a pool of more than 1,300 participating companies across all tracks and categories, Axena Health is recognized in the Best in Class Track for Women’s and Family Health.
“Too many women plan their days around bladder or bowel leakage without knowing that effective, non-invasive treatment is available,” said Samantha Pulliam, MD, FACOG, CEO and Chief Medical Officer of Axena Health. “Axena Health’s goal is to change that by expanding access to clinically proven pelvic health treatment that fits into women’s everyday lives. This recognition as a finalist affirms our team’s efforts to close longstanding gaps in care and advance the mission that drives everything we do: redefining the standard of care for women’s pelvic health.”
Now in its eighth year, the Digital Health Hub Awards celebrate organizations that demonstrate excellence in leveraging digital advancements to enhance healthcare services and patient outcomes. Axena Health was selected as a finalist from a pool of more than 1,300 submissions across all tracks and categories.
“The transition from Quarterfinalist to Finalist is where the competition really gets exciting,” said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation. “We’re seeing companies move beyond promising ideas to solutions that are changing how healthcare is delivered, experienced, and accessed. Our finalists represent an extraordinary range of innovation, and we can’t wait to bring their achievements to the stage at HLTH in November.”
Representatives from Axena Health will attend HLTH USA in November to connect with healthcare leaders, clinicians and industry innovators and discuss how digital health technologies can help expand access to evidence-based treatment for pelvic floor disorders.
Axena Health is working to expand access to effective, evidence-based treatment for urinary and chronic fecal incontinence through its flagship product, the Leva® Pelvic Health System. The clinician-prescribed program combines FDA-cleared technology with personalized coaching, educational resources and progress tracking to bring supervised pelvic floor muscle training into women’s homes.
Available by prescription from clinicians, the Leva Pelvic Health System offers a convenient, non-invasive, medication-free treatment in just five minutes a day. The technology provides precise, real-time visualization of pelvic movement to guide pelvic floor muscle training while enabling clinicians to monitor patient progress and engagement. The treatment is supported by a growing body of clinical research, including multiple clinical trials and peer-reviewed publications demonstrating its efficacy in treating urinary and chronic fecal incontinence. To learn more about Leva, visit levacares.com.
About Axena Health
Axena Health, Inc. is dedicated to improving the lives of women with pelvic floor disorders. Axena Health’s flagship product, the Leva® Pelvic Health System, offers a novel, effective, first-line treatment for urinary incontinence (UI) and chronic fecal incontinence (FI), underreported conditions affecting over 78 million and 12 million women in the U.S. alone. Axena Health’s technology enables non-invasive, drug-free treatment via precise visualization of movement in real time during pelvic floor muscle training, while monitoring usage and progress. For more information, please visit www.axenahealth.com or www.levacares.com and follow Axena Health on LinkedIn, Facebook and Instagram.
About Digital Health Hub Foundation
Our mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017, on the campus of UCSF in San Francisco, our now 30,000 member community consists of thousands of early-to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring together the industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has.
About the Leva® Pelvic Health System
The Leva® Pelvic Health System offers an innovative, non-invasive, medication-free way for women to treat urinary incontinence (UI) and chronic fecal incontinence (FI) — at home in just five minutes a day. Combining a small FDA-cleared vaginal motion sensor with integrated software, the Leva System offers precise, real-time visualization of pelvic movement, progress tracking and active physician involvement, all of which support improved treatment outcomes. The Leva System is available by prescription only, enabling physician engagement in each patient’s success while also offering scalable first-line treatment of UI and chronic FI. The Leva System has multiple clinical trials and published data from globally recognized medical centers supporting its efficacy in treating UI, including two studies in Obstetrics and Gynecology (The Green Journal), the official publication of the American College of Obstetricians and Gynecologists (ACOG).
Important Indication and Other Information for the Leva® Pelvic Health System
The Leva® Pelvic Health System is intended for (1) strengthening of pelvic floor muscles, (2) rehabilitation and training of weak pelvic floor muscles for the treatment of stress, mixed, and mild to moderate urgency urinary incontinence (including overactive bladder) in women and (3) rehabilitation and training of weak pelvic floor muscles for the first-line treatment of chronic fecal incontinence (>3-month uncontrolled passage of feces) in women. This device interacts with the user via smartphone technology. Treatment with the Leva System is by prescription and is not for everyone. Please talk to your prescriber to see if Leva System is right for you. Your prescriber should discuss all potential benefits and risks with you. Do not use Leva System while pregnant, or if you think you may be pregnant, unless authorized by your doctor. For a complete summary of the risks and instructions for the Leva System, see its Instructions for Use available at www.levacares.com.
Contacts
Axena Health
Makenna Lukens
[email protected]
